<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oncotarget</journal-id><journal-id journal-id-type="iso-abbrev">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">Oncotarget</journal-id><journal-id journal-id-type="publisher-id">ImpactJ</journal-id><journal-title-group><journal-title>Oncotarget</journal-title></journal-title-group><issn pub-type="epub">1949-2553</issn><publisher><publisher-name>Impact Journals LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5564761</article-id><article-id pub-id-type="pmid">28484081</article-id><article-id pub-id-type="publisher-id">17329</article-id><article-id pub-id-type="doi">10.18632/oncotarget.17329</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Jianbin</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fan</surname><given-names>Liqiao</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Qun</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tan</surname><given-names>Bibo</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hua</surname><given-names>Kelei</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Guobin</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref></contrib></contrib-group><aff id="A1"><sup>1</sup> Department of General Surgery, The Fourth Affiliated Hospital of Hebei Medical University, Hebei, China</aff><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Yong Li, <email>li_yong_hbth@126.com</email></corresp></author-notes><pub-date pub-type="collection"><day>25</day><month>7</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>21</day><month>4</month><year>2017</year></pub-date><volume>8</volume><issue>30</issue><fpage>49201</fpage><lpage>49216</lpage><history><date date-type="received"><day>8</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>11</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>Copyright: &#169; 2017 Gu et al.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link> (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><sec><title>Aim</title><p>Stomach adenocarcinoma (STAD) is a common malignancy worldwide. This study aimed to identify the aberrantly expressed long non-coding RNAs (lncRNAs) in STAD.</p></sec><sec><title>Results</title><p>Total of 74 DElncRNAs and 449 DEmRNAs were identified in STAD compared with paired non-tumor tissues. The DElncRNA/DEmRNA co-expression network was constructed, which covered 519 nodes and 2993 edges. The qRT-PCR validation results of DElncRNAs were consistent with our bioinformatics analysis based on RNA-sequencing. The DEmRNAs co-expressed with DElncRNAs were significantly enriched in gastric acid secretion, complement and coagulation cascades, pancreatic secretion, cytokine-cytokine receptor interaction and Jak-STAT signaling pathway. The expression levels of the nine candidate DElncRNAs in TCGA database were compatible with our RNA-sequencing. FEZF1-AS1, HOTAIR and LINC01234 had the potential diagnosis value for STAD.</p></sec><sec><title>Materials and Methods</title><p>The lncRNA and mRNA expression profile of 3 STAD tissues and 3 matched adjacent non-tumor tissues was obtained through high-throughput RNA-sequencing. Differentially expressed lncRNAs/mRNAs (DElncRNAs/DEmRNAs) were identified in STAD. DElncRNA/DEmRNA co-expression network construction, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were conducted to predict the biological functions of DElncRNAs. Quantitative real-time polymerase chain reaction (qRT-PCR) was subjected to validate the expression levels of DEmRNAs and DElncRNAs. Moreover, the expression of DElncRNAs was validated through The Cancer Genome Atlas (TCGA) database. The diagnosis value of candidate DElncRNAs was accessed by receiver operating characteristic (ROC) analysis.</p></sec><sec><title>Conclusions</title><p>Our work might provide useful information for exploring the tumorigenesis mechanism of STAD and pave the road for identification of diagnostic biomarkers in STAD.</p></sec></abstract><kwd-group><kwd>stomach adenocarcinoma</kwd><kwd>expression profile</kwd><kwd>long non-coding RNA</kwd><kwd>co-expression</kwd><kwd>tumorigenesis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>INTRODUCTION</title><p>Stomach cancer is one of common malignancies of digestive tract carcinoma. More than 950,000 new stomach cancer cases and 720,000 deaths occur in 2012 worldwide [<xref rid="R1" ref-type="bibr">1</xref>]. It is divided into stomach adenocarcinoma (STAD) and stomach squamous cell carcinoma (SSCC) based on the histopathologic feature. STAD is the predominant subtype in stomach cancer.</p><p>The regions of highest rates of stomach cancer are in Eastern Asia countries especially in China, Japan and Korea; stomach cancer is almost twice more common in males than females [<xref rid="R1" ref-type="bibr">1</xref>]. Numerous articles indicate that the onset and progression of stomach cancer is likely attributed to the interconnection of H. pylori infection, genetic factors and environment exposure. H. pylori is responsible for 90% new noncardia stomach cancer cases worldwide [<xref rid="R2" ref-type="bibr">2</xref>]. Higher expression of &#946;2-AR, VEGF and PODXL is significantly associated with poorer survival and higher risk of recurrence in patients with stomach cancer, [<xref rid="R3" ref-type="bibr">3</xref>&#8211;<xref rid="R5" ref-type="bibr">5</xref>]. rs2494752 AG/GG variant genotype in AKT1, rs1034528 CG/CC and rs3806317 GA/GG variants in mTOR, and copy-number loss of CYCLOPS and STOP genes are related to stomach cancer susceptibility and carcinogenesis [<xref rid="R6" ref-type="bibr">6</xref>&#8211;<xref rid="R8" ref-type="bibr">8</xref>]. However, pathological mechanism of STAD is largely unknown.</p><p>microRNAs (miRNAs) with 20&#8211;25 nucleotides belong to non-coding RNAs, which function as promoting or repressing roles in cellular process tumorigenesis [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>]. miRNA-222 promotes cell migration by suppressing p27kip1 in STAD [<xref rid="R11" ref-type="bibr">11</xref>]. Over-expression of miR-296-5p promotes cell proliferation in stomach cancer by decreased expression of Caudal-related [<xref rid="R12" ref-type="bibr">12</xref>]. Piwi-interaction RNAs (piRNA), as a class of non-coding RNAs, is involved in tumorigenesis of several cancers. piR-823 expression is markedly reduced in gastric cancer tissues compared to non-cancerous tissues and over-expression of piR-823 suppresses cell growth in gastric cancer [<xref rid="R13" ref-type="bibr">13</xref>]. piR-651 is significantly up-regulated in gastric cancer and higher expression of piR-651 predicts advanced TNM stage. Knock down of piR-651 inhibits cell growth and arrests G2/M phase in gastric cancer [<xref rid="R14" ref-type="bibr">14</xref>]. The transcripts with longer than 200 nucleotides, not translated into proteins, are defined as long non-coding RNAs (lncRNAs) [<xref rid="R15" ref-type="bibr">15</xref>]. lncRNAs are known to implicate in splicing, recruiting transcription factors and mRNA stability [<xref rid="R16" ref-type="bibr">16</xref>]. Mounting reports demonstrate that aberrant expression of lncRNAs emerge as vital regulator of diverse biological processes in cancers, such as tumorigenesis, development and metastasis [<xref rid="R15" ref-type="bibr">15</xref>].</p><p>In this study, we used high-throughput RNA-sequencing to obtain lncRNA and mRNA expression profile in STAD, identified differentially expressed lncRNAs/mRNAs in STAD compared to adjacent non-tumor tissues and constructed lncRNA/mRNA co-expression network. The diagnostic value of candidate DEmRNAs was validated in TCGA database. Our study might provide valuable information for exploring tumorigenesis mechanism in STAD and identification of potential biomarkers for STAD diagnosis.</p></sec><sec id="s2"><title>RESULTS</title><sec id="s2_1"><title>RNA-sequencing of STAD tissues</title><p>STAD and adjacent non-tumor tissues obtained from three patients were applied for RNA-sequencing. All of three patients were diagnosed as diffuse Lauren type and T4N1M0 stage of STAD (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1</xref>). After raw reads trim, respective 1.05 &#215; 10<sup>8</sup>, 0.95 &#215; 10<sup>8</sup>, 1.15 &#215; 10<sup>8</sup> clean reads were generated from three STAD samples, and 1.04 &#215; 10<sup>8</sup>, 0.89 &#215; 10<sup>8</sup>, 0.968 &#215; 10<sup>8</sup> clean reads were generated from three corresponding adjacent non-tumor tissues, as <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2</xref> shown. All of the clean reads were aligned with the human reference genome (hg.19). The mapped ratio of all samples was above 70% (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 3</xref>).</p></sec><sec id="s2_2"><title>lncRNAs and mRNAs expression profile</title><p>Respective 15929 lncRNAs and 20205 mRNAs were mapped with the human reference genome hg. 19. Total of 74 significantly differential expression lncRNAs (DElncRNAs) with at least 2-fold change were identified in STAD compared with adjacent non-tumor tissues (<xref ref-type="supplementary-material" rid="SD2">Supplementary Table 4</xref>). 43 DElncRNAs were up-regulated and 31 DElncRNAs were down-regulated in STAD, which were described as volcano plot (Figure <xref ref-type="fig" rid="F1">1A</xref>). As Figure <xref ref-type="fig" rid="F1">1B</xref> shown, 449 DEmRNAs including 238 up- and 211 down-regulated DEmRNAs were screened in STAD (<xref ref-type="supplementary-material" rid="SD3">Supplementary Table 5</xref>).</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Volcano spot of lncRNA and mRNA expression in stomach adenocarcinoma</title><p>(<bold>A</bold>) volcano spot of lncRNA expression in cancer group and control group; (<bold>B</bold>) volcano spot of mRNA expression in cancer group and control group. C indicated stomach adenocarcinoma and N indicated adjacent non-tumor samples. Red spot and blue spot respectively indicated up- and down-regulated genes in stomach adenocarcinoma.</p></caption><graphic xlink:href="oncotarget-08-49201-g001"/></fig><p>Hierarchical clustering of the lncRNAs and mRNAs expression profile was performed by using hcluster in R language. Spearman Pearson correlation between 6 samples were calculated. Hierarchical clustering of the expression of the 74 lncRNAs and 449 mRNAs displayed that there were obvious discrimination between STAD and adjacent non-tumor tissues (Figure <xref ref-type="fig" rid="F2">2</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1</xref>). The most significantly up-regulated DElncRNA was LOC105377924 and the most significantly down-regulated DElncRNA was SEMA3B-AS1 in STAD (Table <xref ref-type="table" rid="T1">1</xref>). S100A2 and NTRK3 were the most significantly up- and down-regulated DEmRNAs in stomach STAD, as Table <xref ref-type="table" rid="T2">2</xref> shown.</p><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Hierarchical clustering analysis of the expression levels of DElncRNAs in stomach adenocarcinoma and adjacent non-tumor tissues</title><p>Row and column represented DElncRNAs and tissue samples. The color scale indicated log<sub>10</sub>FPKM of the expression levels of DElncRNAs. Red and green indicated up- and down-regulation. C represented stomach adenocarcinoma tissues and N represented adjacent non-tumor tissues.</p></caption><graphic xlink:href="oncotarget-08-49201-g002"/></fig><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>The top 15 up- and down-regulated DElncRNAs in STAD</title></caption><table-wrap-foot><p>DElncRNA: differentiated expressed long non-coding RNA; STAD: stomach adenocarcinoma; FDR: false discovery rate; FC: fold change.</p></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>The top 15 up- and down-regulated DEmRNAs in STAD</title></caption><table-wrap-foot><p>DEmRNA: differentially expressed mRNA; STAD: stomach adenocarcinoma; FDR: false discovery rate; FC: fold change.</p></table-wrap-foot></table-wrap><p>In our study, 74 identified DElncRNAs were widely distributed in all autosomes and chromosomes X (Figure <xref ref-type="fig" rid="F3">3A</xref>). 449 DEmRNAs were distributed in all autosomes, chromosomes X and chromosomes Y (Figure <xref ref-type="fig" rid="F3">3A</xref>). Based on the annotation results, the biotype of 74 DElncRNAs was divided into 5 categories. 22 DElncRNAs (29.7%) were natural antisense, 35 DElncRNAs (47.3%) were lincRNAs, 4 DElncRNAs (5.4%) were processed transcripts, 5 DElncRNAs (6.8%) was sense intronic and 8 DElncRNAs (10.8%) were others (Figure <xref ref-type="fig" rid="F3">3B</xref>).</p><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Circos plot of the distribution of DElncRNAs/DEmRNAs on chromosomes and the biotype of DElncRNAs</title><p>(<bold>A</bold>) circos plot. The outer layer of blue cycle was the chromosome map of the human genome. The larger inner layer and smaller inner layer represented the distribution of DEmRNAs and DElncRNAs on different chromosome, respectively. Red color indicated up-regulation and blue color indicated down-regulation. The height of the bar in the larger inner layer and in the smaller inner layer represented log<sub>2</sub>FC of expression levels of DElncRNAs and DEmRNAs. (<bold>B</bold>) The biotype of 74 DElncRNAs was classified into five categories. lincRNA indicated long intergenic non-protein coding RNA.</p></caption><graphic xlink:href="oncotarget-08-49201-g003"/></fig></sec><sec id="s2_3"><title>DElncRNA/DEmRNA co-expression network</title><p>In order to investigate the potential functions of DElncRNAs in STAD, the Pearson correlation coefficient (PCC) indicating the co-expression relationship between 74 DElncRNAs and 449 DEmRNAs were calculated based on the expression levels of DElncRNAs and DEmRNAs. DElncRNA/DEmRNA co-expression pairs with |PCC| &#8805; 0.9 were our concerns. In <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2</xref>, total of 74 DElncRNAs and 445 DEmRNAs were involved in the co-expressed network, which consisted of 519 nodes and 2993 edges. LINC01105 (ENSG00000232044, Figure <xref ref-type="fig" rid="F4">4B</xref>), RP11-440D17.4 (ENSG00000273305), RP11-617F23.1 (ENSG00000259291) and LINC00261 (ENSG0000 0259974, Figure <xref ref-type="fig" rid="F4">4A</xref>) were the hub DElncRNAs in the network, which had high connectivity with DEmRNAs.</p><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>Sub-networks of DElncRNAs/DEmRNAs co-expression</title><p>(<bold>A</bold>) the sub-network of LINC00261; (<bold>B</bold>) the sub-network of LINC01105; (<bold>C</bold>) the sub-network of FEZF1-AS1; (<bold>D</bold>) the sub-network of H19; (<bold>E</bold>) the sub-network of HOTAIR; (<bold>F</bold>) the sub-network of SNHG3; (<bold>G</bold>) the sub-network of SEMA3B-AS1; (<bold>H</bold>) the sub-network of LINC00982; (<bold>I</bold>) the sub-network of LINC105377924. Circular node represented DEmRNA and rectangle node represented DElncRNA. Yellow was up-regulated DEmRNA and green was down-regulated DEmRNAs; Red indicated up-regulated DElncRNA and blue indicated down-regulated DElncRNA.</p></caption><graphic xlink:href="oncotarget-08-49201-g004"/></fig></sec><sec id="s2_4"><title>GO and KEGG pathway enrichment analyses</title><p>In order to predict the potential functions of DEmRNAs co-expressed with DElncRNAs, GO and KEGG pathway were adopted to demonstrate it. 445 DEmRNAs co-expressed with DElncRNAs were significantly enriched in extracellular matrix and extracellular region of cell component, cell adhesion and biological adhesion in biological process, calcium ion binding and receptor binding in molecular function (Table <xref ref-type="table" rid="T3">3</xref>). Those DEmRNAs were significantly enriched in several KEGG signaling pathways. Gastric acid secretion, complement and coagulation cascades, pancreatic secretion, cytokine-cytokine receptor interaction and Jak-STAT signaling pathway were the top pathways associated with STAD (Table <xref ref-type="table" rid="T4">4</xref>).</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>GO term enrichment of dysregulated mRNAs</title></caption><table-wrap-foot><p>FDR: false discovery rate.</p></table-wrap-foot></table-wrap><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><title>KEGG pathway enrichment of dysregulated mRNAs in STAD</title></caption><table-wrap-foot><p>STAD: stomach adenocarcinoma; FDR: false discovery rate.</p></table-wrap-foot></table-wrap><p>Moreover, those DEmRNAs (underlined genes in Table <xref ref-type="table" rid="T4">4</xref>) co-expressed with DElncRNAs shown in Figure <xref ref-type="fig" rid="F3">3</xref> were significantly enriched in abovementioned signaling pathways. KCNE2 (co-expressed with LINC01105 and SEM3B-AS1), KCNJ15 (co-expressed with LINC01105 and LINC00261), SLC26A7 (co-expressed with SEM3B-AS1) and SSTR2 (co-expressed with LINC00982) were significantly enriched in gastric acid secretion; CLCA4 co-expressed with H19 and HOTAIR was significantly enriched in pancreatic secretion; CSF3R co-expressed with H19 and HOTAIR was significantly enriched in pathways in cancer, Jak-STAT signaling pathway and cytokine-cytokine receptor interaction; CXCL5 co-expressed with H19 and HOTAIR was significantly enriched in cytokine-cytokine receptor interaction; RYR2 co-expressed with LINC00261 and LINC01105 was significantly enriched in pancreatic secretion and calcium signaling pathway.</p></sec><sec id="s2_5"><title>qRT-PCR validation of DElncRNA and DEmRNAs</title><p>DElncRNAs and DEmRNAs were identified in our study through high throughout sequencing and bioinformatics analysis. qRT-PCR was subjected to validate the expression levels of DElncRNAs and DEmRNAs in ten STAD tissues and ten matched adjacent tumor tissues. Three DElncRNAs and one DEmRNAs were chose for verification. As Figure <xref ref-type="fig" rid="F5">5A and 5C</xref> shown, LINC00982 and LINC00261 (<italic>P</italic> &lt; 0.01) were down-regulated in STAD compared with controls. SHNG3 was significantly up-regulated in STAD tissues in Figure <xref ref-type="fig" rid="F5">5B</xref> (<italic>P</italic> &lt; 0.01). In our DEmRNA expression profile analysis, FOXA2 was not significantly down-regulated (FDR &gt; 0.05), but it had the down-regulated tendency in STAD. In the qRT-PCR validation, FOXA2 (<italic>P</italic> &lt; 0.01) was significantly down-regulated in STAD (Figure <xref ref-type="fig" rid="F5">5D</xref>). In generally, the verification results of qRT-PCR were consistent with our bioinformatics analysis.</p><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><title>qRT-PCR validation of dysregulated DElncRNAs and DEmRNAs in STAD compared with matched non-tumor tissues</title><p>(<bold>A</bold>) The expression level of lncRNA LINC00982; (<bold>B</bold>) The expression level of lncRNA SNHG3; (<bold>C</bold>) The expression level of lncRNA LINC00261; (<bold>D</bold>) The expression level of FOXA2. STAD indicated stomach adenocarcinoma; CON indicated paired adjacent non-tumor tissues. * represented <italic>P</italic> &lt; 0.05 and ** represented <italic>P</italic> &lt; 0.01.</p></caption><graphic xlink:href="oncotarget-08-49201-g005"/></fig></sec><sec id="s2_6"><title>The expression levels of candidate DElncRNAs were analyzed in the TCGA datasets</title><p>The lncRNA expression profile of 285 STAD tissues (case group) and 33 adjacent non-tumor tissues (control group) were retrieved from TCGA database. The difference of expression levels of the nine DElncRNAs between STAD and non-tumor tissues were analyzed and were depicted using box-plots, which was visually illustrated by median and inter-quartile range. As Figure <xref ref-type="fig" rid="F6">6B, 6G and 6H</xref> shown, the expression levels of LINC01105 (<italic>P</italic> = 0.002724), SEMA3B-AS1 (<italic>P</italic> = 0.003923) and LINC00982 (<italic>P</italic> = 0.001156) were significantly down-regulated in case group compared with control group. In addition, the expression levels of FEZF1-AS1 (<italic>P</italic> = 2.2e-16), H19 (<italic>P</italic> = 2.37e-07), HOTAIR (<italic>P</italic> = 2.2e-16) and LINC01234 (<italic>P</italic> = 6.78e-16) in case group were significantly higher than that in control group, as Figure <xref ref-type="fig" rid="F6">6C&#8211;6E and 6I</xref> revealed. In addition, the difference of expression levels of LINC00261 and SNHG3 between case group and control group was not significant, but LINC00261 expression had the down-regulated tendency and SNHG3 expression had the up-tendency in case group compared with control group (Figure <xref ref-type="fig" rid="F6">6A and 6F</xref>). In general, the results of cross validation indicated that the expression patterns of candidate DElncRNAs in TCGA database was compatible with our RNA-sequencing and bioinformatics analyses.</p><fig id="F6" orientation="portrait" position="float"><label>Figure 6</label><caption><title>The cross validation of the expression levels of candidate DElncRNAs in STAD tissues based on TCGA database</title><p>(<bold>A</bold>) LINC00261; (<bold>B</bold>) LINC01105; (<bold>C</bold>) FEZF1-AS1; (<bold>D</bold>) H19; (<bold>E</bold>) HOTAIR; (<bold>F</bold>) SNHG3; (<bold>G</bold>) SEMA3B-AS1; (<bold>H</bold>) LINC00982; (<bold>I</bold>) LINC01234. Case group and control group indicated STAD tissues and adjacent non-tumor tissues.</p></caption><graphic xlink:href="oncotarget-08-49201-g006"/></fig></sec><sec id="s2_7"><title>ROC curve analysis</title><p>In order to access the discriminatory ability of the nine candidate DElncRNAs among 285 STAD tissues and 33 adjacent non-tumor tissues generated from TCGA database, ROC curve analyses were conducted and AUC were calculated. As Figure <xref ref-type="fig" rid="F7">7B&#8211;7E, 7H and 7I</xref> shown, the AUC of LINC01105 (0.731), FEZF1-AS1 (0.914), H19 (0.709), HOTAIR (0.923), LINC00982 (0.740) and LINC01234 (0.894) was more than 0.7; the AUC of LINC00261 (0.591, Figure <xref ref-type="fig" rid="F7">7A</xref>), SNHG3 (0.568, Figure <xref ref-type="fig" rid="F7">7F</xref>) and SEMA3B-AS1 (0.694, Figure <xref ref-type="fig" rid="F7">7G</xref>) was less than 0.7.</p><fig id="F7" orientation="portrait" position="float"><label>Figure 7</label><caption><title>The discriminatory ability of the evaluated DElncRNAs between STAD tissues and adjacent non-tumor tissues was accessed with ROC curve</title><p>(<bold>A</bold>) LINC00261; (<bold>B</bold>) LINC01105; (<bold>C</bold>) FEZF1-AS1; (<bold>D</bold>) H19; (<bold>E</bold>) HOTAIR; (<bold>F</bold>) SNHG3; (<bold>G</bold>) SEMA3B-AS1; (<bold>H</bold>) LINC00982; (<bold>I</bold>) LINC01234.</p></caption><graphic xlink:href="oncotarget-08-49201-g007"/></fig><p>FEZF1-AS1, HOTAIR and LINC01234 had the largest AUC in those nine DElncRNAs. For STAD diagnosis, the sensitivity and specificity of FEZF1-AS1 was 93.9% and 77.9% (Figure <xref ref-type="fig" rid="F7">7C</xref>); the sensitivity and specificity of HOTAIR was 87.9% and 87.7% (Figure <xref ref-type="fig" rid="F7">7E</xref>); the sensitivity and specificity of LINC01234 was 93.9% and 76.8% (Figure <xref ref-type="fig" rid="F7">7I</xref>), respectively.</p></sec></sec><sec id="s3"><title>DISCUSSION</title><p>LncRNAs are long non-coding transcripts with longer than 200 nucleotides. They are expressed at lower level compared to protein-coding mRNA [<xref rid="R17" ref-type="bibr">17</xref>]. Mounting evidence demonstrate that DElncRNAs are linked to multiple human diseases, such as colorectal cancer, breast cancer and lung cancer [<xref rid="R18" ref-type="bibr">18</xref>].</p><p>In our study, the landscape of lncRNAs in STAD tissues was obtained by RNA-sequencing . Total of 74 DElncRNAs and 449 DEmRNAs were identified in STAD. The expression levels of LINC00982, LINC00261 and SNHG3 of DElncRNAs and FOXA2 of DEmRNA were verified through qRT-PCR, the results of which were generally consistent with high-throughput sequencing. DElncRNAs distributed on all chromosomes except Y chromosomes and DEmRNAs distributed on all chromosomes including X and Y chromosomes. The DElncRNA/DEmRNA co-expression network was constructed for predicting the potential functions of DElncRNAs in STAD.</p><p>In accordance with the previous studies, lncRNA H19 and lncRNA HOTAIR were up-regulated and LINC00261 was down-regulated in stomach cancer. In our data, H19 and HOTAIR was up-regulated with 23.5 and 17.5 fold in STAD, respectively. H19 co-expressed with 72 DEmRNAs and 6 DElncRNAs (Figure <xref ref-type="fig" rid="F4">4D</xref>). Increased expression of H19 contributes to tumor suppressor p53 inactivation in stomach cancer, which promotes cell proliferation, migration, invasion and metastasis in stomach cancer [<xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R20" ref-type="bibr">20</xref>]. Increased H19 is significantly correlated to advanced TNM stage and lymph node metastasis, while leads to poorer overall survival in patients with STAD [<xref rid="R21" ref-type="bibr">21</xref>]. Circulating H19 is up-regulated in plasma of patients with STAD compared to healthy controls and it might be promising biomarker of STAD patients [<xref rid="R22" ref-type="bibr">22</xref>]. In the DElncRNA/DEmRNA co-expression network, HOTAIR positively correlated with 67 DEmRNAs and 5 DElncRNAs, such as H19 (Figure <xref ref-type="fig" rid="F4">4E</xref>). Over-expression of HOTAIR promotes the epithelia-to-mesenchymal transition, cell invasion, cell metastasis and it is associated with unfavorable survival of patients with STAD [<xref rid="R23" ref-type="bibr">23</xref>&#8211;<xref rid="R26" ref-type="bibr">26</xref>].</p><p>LINC00982 and LINC00261 were down-regulated and SNHG3 significantly up-regulated in SATD (Figure <xref ref-type="fig" rid="F3">3</xref>), which were consistent with our high-throughput sequencing. The recent study demonstrates that decreased LINC000982 contributes to cell proliferation, cell cycle progression, poor overall survival and disease-free survival; and its over-expression suppresses cell proliferation and renders cell cycle arrest in stomach cancer [<xref rid="R27" ref-type="bibr">27</xref>]. LINC00261 is down-regulated in stomach cancer and co-expressed with 85 DEmRNAs in our study (Figure <xref ref-type="fig" rid="F4">4A</xref>). Lower expression of LINC00261 correlates with deeper tumor invasion, poorer differentiation and lymph node metastasis in stomach cancer [<xref rid="R28" ref-type="bibr">28</xref>]. Currently, the potential functions and mechanism of SNHG3 in STAD are largely unclear. Our study was the first time to report that SNHG3 was over-expressed in STAD. It is reported that SNHG3 is significantly up-regulated in hepatocellular carcinoma (HCC) compared with paired non-tumor tissues; up-regulation of SNHG3 is correlated with overall survival, recurrence-free survival and relapse in HCC [<xref rid="R29" ref-type="bibr">29</xref>]. The aforementioned information suggests that increased SNHG3 might contribute to the carcinogenesis of STAD.</p><p>FEZF1-AS1 is up-regulated in colorectal carcinoma (CRC), which promotes aggressive behaviors of CRC cells, including cell proliferation, cell migration and cell metastasis [<xref rid="R30" ref-type="bibr">30</xref>]. In our results, FEZF1-AS1 was one of top 10 significantly up-regulated DElncRNAs with 38 fold up-regulation in STAD. FEZF1-AS1 was identified as a novel lncRNA associated with STAD tumorigenesis in our study. LINC01234 is up-regulated in esophageal squamous cell carcinoma (ESCC) and the three-lncRNA signature including LINC01234 could accurately predict survival of patients with ESCC [<xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R32" ref-type="bibr">32</xref>]. LINC01234 had almost 36 fold up-regulation in STAD. The potential roles of LINC01234 in STAD tumorigenesis need to be explored in the future work.</p><p>445 out of 449 DEmRNAs were co-expressed with 74 DElncRNAs. In order to predict the potential functions of DElncRNAs, GO terms and KEGG signaling pathways of 445 DEmRNAs were enriched, respectively. The results of significant GO annotation, such as cell adhesion, biological adhesion, calcium ion binding and receptor binding, indicated that DElncRNAs and DEmRNAs associated with these GO terms might contribute to STAD tumorigenesis. Several KEGG pathways were enriched from DEmRNAs, such as gastric acid secretion, complement and coagulation cascades, pancreatic secretion, cytokine-cytokine receptor interaction and Jak-STAT signaling pathway, suggesting that DElncRNAs and DEmRNAs might play essential roles through involving in those pathways in STAD.</p><p>Except of H19, HOTAIR, LINC000982 and LINC00261, most of DElncRNAs were identified as novel lncRNAs associated with STAD, such as the most significantly up-regulated LOC105377924 (Figure <xref ref-type="fig" rid="F4">4I</xref>), the most significantly down-regulated SEMA3B-AS1 (Figure <xref ref-type="fig" rid="F4">4G</xref>), and LINC01105 (ENSG00000232044, Figure <xref ref-type="fig" rid="F4">4B</xref>), which had the highest degree with DEmRNAs in the co-expression network. Whether those novel DElncRNAs refer to the initiation and development of STAD needs to be clarified through <italic>in vivo</italic> and <italic>in vitro</italic> experiments in the future work. The ROC curve analyses indicated that lncRNA FEZF1-AS1, HOTAIR and LINC01234 might be potential biomarkers for STAD diagnosis. In the further work, large cohort of STAD patients needs to be enrolled and the discriminatory ability of those DElncRNAs in STAD diagnosis needs to be further validated in clinical practice.</p><p>Our work reported the dysregulated lncRNAs involved in STAD by using high-throughput RNA sequencing. Our study might be the foundation for future investigation for diagnostic biomarkers for STAD and illumination of tumorigenesis mechanisms of STAD.</p></sec><sec sec-type="methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4_1"><title>Patients and samples</title><p>STAD tissues and adjacent non-tumor tissues were obtained from patients received the tumor radical resection in the Fourth Affiliated Hospital of Hebei Medical University. Patients were received none of chemo- or radiotherapy before gastrectomy. The pathological type of patients with stomach cancer was explicitly diagnosed by histopathologic examination. The details of clinical features including gender, age, Lauren type, histologic type and TNM stage were collected. Lastly, 3 subjects with STAD were enrolled into our study.</p><p>The study was approved by the Ethics Committee of the Fourth Affiliated Hospital of Hebei Medical University and informed written consent was obtained from all patients. The research complied with the principles of the Declaration of Helsinki.</p></sec><sec id="s4_2"><title>Library preparation and high-throughput sequencing</title><p>Total RNA of collected specimens was extracted by TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manual instruction. Firstly, total RNA was subjected to ribosomal RNA removal by Ribo-Zero Magnetic kit (EpiCentre, Mandison, WI, USA); secondly, cDNA library was constructed by Truseq RNA sample Prep Kit (Illumina, Inc., San Diego, CA, USA). RNA was purified and fragmented into 200 base pairs; RNA fragment primed with random hexamer primers were applied for the first cDNA strand synthesis; then the second cDNA strand was synthesized and dUTP was used instead of dTTP; the double cDNA strands were underwent end pair, 3&#8242;end adenylation and adapter ligation; the second cDNA strand was digested by UNG enzyme (Illumina, Inc., San Diego, CA, USA). Thirdly, libraries were amplified through polymerase chain reaction for 15 cycles, purified through Certified Low Range Ultra Agarose (Bio-Rad) and quantified through Picogreen (Molecular probes) on TBS380 (Turner Biosystems). Then bridge PCR was performed on cBot. Lastly, each library was loaded into one lane of the Illumina HiSeq 4000 for sequencing.</p></sec><sec id="s4_3"><title>Quality control of raw sequence</title><p>The raw image data obtained from high-throughput RNA-sequencing was translated into raw FASTQ sequence data by Base Calling. Raw RNA-Seq data were filtered using FASTxtool SeqPrep (<ext-link ext-link-type="uri" xlink:href="https://github.com/jstjohn/SeqPrep">https://github.com/jstjohn/SeqPrep</ext-link>) and Sickle (<ext-link ext-link-type="uri" xlink:href="https://github.com/najoshi/sickle">https://github.com/najoshi/sickle</ext-link>) according to the following criteria: (1) reads containing sequencing adaptors; (2) nucleotides with a quality score &lt; 20 were trimmed from the end of the sequence; once the quality value of reads after being trimmed less than 10, the whole sequence was abandoned; (3) N base rate of raw reads with more than 10% were discarded; (4) raw reads with base pairs less than 20 after adapter removal and trim was abnegated.</p></sec><sec id="s4_4"><title>Clean reads mapping</title><p>Clean reads were aligned with the human reference genome, Ensemble GRCh38 v 84 (hg19), by using TopHat and Ensemble gene annotation. TopHat allows a maximum of two mismatches when mapping the reads to the reference genome. Fragment assembly and the relative expression of the reads with the normalized RNA-Seq fragment counts were processed by Cufflinks [<xref rid="R33" ref-type="bibr">33</xref>]. The assembled transcripts were merged to an integrated transcriptome of by using Cuffmerge. Fragments per kilobase of exon per million mapped reads (FPKM) were used to determine the transcription abundance of lncRNA and mRNA.</p></sec><sec id="s4_5"><title>Differentially expressed lncRNA and differentially expressed mRNA analysis</title><p>Cuffdiff was used to calculate the FPKM of each reads. Paired <italic>t</italic>-tests were carried out for expression testing between STAD and adjacent non-tumor tissues [<xref rid="R33" ref-type="bibr">33</xref>]. FDR &lt; 0.05 and |log<sub>2</sub>FC &gt; 1| was selected as the criteria for DElncRNAs and FDR &lt; 0.05 was set as the threshold of DEmRNAs after applying Benjamini-Hochberg correction for multiple test.</p></sec><sec id="s4_6"><title>Co-expression analysis and network construction between DElncRNAs and DEmRNAs</title><p>DElncRNA-DEmRNA co-expression network was performed to explore the critical roles of DElncRNA and DEmRNA in progression of STAD. Pearson correlation coefficient (PCC) reflecting co-expression relationship between DElncRNAs and DEmRNAs were calculated according to their expression levels. DElncRNA-DEmRNA pairs with |PCC| &#8805; 0.90 were retained for network construction [<xref rid="R34" ref-type="bibr">34</xref>]. The DElncRNA-DEmRNA network was visualized by Cytoscape 3.1 (<ext-link ext-link-type="uri" xlink:href="http://cytoscape.org/">http://cytoscape.org/</ext-link>) [<xref rid="R35" ref-type="bibr">35</xref>].</p></sec><sec id="s4_7"><title>Gene Ontology and KEGG enrichment analysis</title><p>Gene Ontology (GO) function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were used to predict the biological function of DEmRNAs [<xref rid="R36" ref-type="bibr">36</xref>]. Online GeneCoDis3 (<ext-link ext-link-type="uri" xlink:href="http://genecodis.cnb.csic.es/analysis">http://genecodis.cnb.csic.es/analysis</ext-link>) was used to enrich GO terms and KEGG pathways [<xref rid="R37" ref-type="bibr">37</xref>, <xref rid="R38" ref-type="bibr">38</xref>]. FDR &lt; 0.05 was set as the cut-off for significant GO terms and KEGG pathways.</p></sec><sec id="s4_8"><title>Quantitative real-time polymerase chain reaction (qRT-PCR)</title><p>Total RNA of STAD and adjacent non-tumor tissues were extracted using Trizol (Invitrogen, CA, USA) according to the manual instructions. The M-MLV Reverse Transcriptase kit (Promega, WI, USA) was used to synthesize the cDNA. qRT-PCR reactions were performed using SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA) on the Rotor gene 3000 (Corbett, Brisbane, Australia). &#946;-actin was used as internal control for mRNA detection. The relative expression of candidate genes was calculated using the 2<sup>&#8722;&#916;&#916;CT</sup> equation [<xref rid="R39" ref-type="bibr">39</xref>]. The PCR primers were shown as <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 6</xref>. At least triple experiments were subjected to qRT-PCR verification.</p></sec><sec id="s4_9"><title>The expression levels of DElncRNAs were validated through lncRNA expression profile generated from The Cancer Genome Atlas database</title><p>The Cancer Genome Atlas (TCGA, <ext-link ext-link-type="uri" xlink:href="https://tcga-data.nci.nih.gov/tcga/">https://tcga-data.nci.nih.gov/tcga/</ext-link>) is a public funded project and has produced multidimensional data at the DNA, RNA and protein levels for a broad range of human tumor types. The Atlas of Noncoding RNAs in Cancer (TANRIC, <ext-link ext-link-type="uri" xlink:href="http://ibl.mdanderson.org/tanric/_design/basic/index.html">http://ibl.mdanderson.org/tanric/_design/basic/index.html</ext-link>) is an open resource for interactive exploration of lncRNAs in the context of TCGA clinical and genomic data. In our study, TANRIC database was employed to retrieve the lncRNA expression profile of STAD based on RNA-sequencing generated from TCGA data. Lastly, the lncRNA expression data of 285 STAD tissues and 33 adjacent non-tumor tissues were retrieved. The difference of expression levels of DElncRNAs between STAD tissues and adjacent non-tumor tissues were compared and were delineated by box-plot.</p></sec><sec id="s4_10"><title>Receiver operating characteristic analyses</title><p>In order to assess the diagnostic value of candidate DElncRNAs, receiver operating characteristic (ROC) analyses were performed using pROC package in R language. The area under the curve (AUC) under binomial exact confidence interval was calculated to generate the ROC curve.</p></sec><sec id="s4_11"><title>Statistical analysis</title><p>Mean &#177; standard deviation and independent-samples <italic>t</italic>-test were used in the statistical analysis. <italic>P</italic> &lt; 0.05 was considered as significant difference. To group samples based on expression values of mRNA and lncRNAs, we performed hierarchical cluster analysis [<xref rid="R40" ref-type="bibr">40</xref>]. These analyses were performed by R platform (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>) [<xref rid="R41" ref-type="bibr">41</xref>]. Circos plot was described as the distribution of DElncRNAs and DEmRNAs in chromosomes.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>SUPPLEMENTARY MATERIALS FIGURES AND TABLES</title><supplementary-material content-type="local-data" id="SD1"><media mimetype="application" mime-subtype="pdf" xlink:href="oncotarget-08-49201-s001.pdf" orientation="portrait" xlink:type="simple" id="d35e2025" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><media mimetype="application" mime-subtype="docx" xlink:href="oncotarget-08-49201-s002.docx" orientation="portrait" xlink:type="simple" id="d35e2027" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><media mimetype="application" mime-subtype="docx" xlink:href="oncotarget-08-49201-s003.docx" orientation="portrait" xlink:type="simple" id="d35e2029" position="anchor"/></supplementary-material></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold>CONFLICTS OF INTEREST</bold></p><p>All of authors declare that they have no conflicts of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R</given-names></name><name><surname>Naishadham</surname><given-names>D</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer statistics, 2012</article-title><source>CA Cancer J Clin</source><year>2012</year><volume>62</volume><fpage>10</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">22237781</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plummer</surname><given-names>M</given-names></name><name><surname>Franceschi</surname><given-names>S</given-names></name><name><surname>Vignat</surname><given-names>J</given-names></name><name><surname>Forman</surname><given-names>D</given-names></name><name><surname>de Martel</surname><given-names>C</given-names></name></person-group><article-title>Global burden of gastric cancer attributable to Helicobacter pylori</article-title><source>Int J Cancer</source><year>2015</year><volume>136</volume><fpage>487</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1002/ijc.28999</pub-id><pub-id pub-id-type="pmid">24889903</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Kaira</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name><name><surname>Yoshinari</surname><given-names>D</given-names></name><name><surname>Yokobori</surname><given-names>T</given-names></name><name><surname>Asao</surname><given-names>T</given-names></name><name><surname>Takeyoshi</surname><given-names>I</given-names></name><name><surname>Oyama</surname><given-names>T</given-names></name></person-group><article-title>Clinical significance of beta2-adrenergic receptor expression in patients with surgically resected gastric adenocarcinoma</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>13885</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1007/s13277-016-5139-2</pub-id><pub-id pub-id-type="pmid">27485115</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Tu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma</article-title><source>Am J Clin Pathol</source><year>2016</year><volume>146</volume><fpage>278</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1093/ajcp/aqw110</pub-id><pub-id pub-id-type="pmid">27543975</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>D</given-names></name><name><surname>Hedner</surname><given-names>C</given-names></name><name><surname>Nodin</surname><given-names>B</given-names></name><name><surname>Larsson</surname><given-names>A</given-names></name><name><surname>Johnsson</surname><given-names>A</given-names></name><name><surname>Eberhard</surname><given-names>J</given-names></name><name><surname>Jirstrom</surname><given-names>K</given-names></name></person-group><article-title>Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma</article-title><source>BMC Clin Pathol</source><year>2016</year><volume>16</volume><fpage>13</fpage><pub-id pub-id-type="doi">10.1186/s12907-016-0034-8</pub-id><pub-id pub-id-type="pmid">27478410</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>MY</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>ML</given-names></name><name><surname>Teng</surname><given-names>XY</given-names></name><name><surname>Li</surname><given-names>QX</given-names></name><name><surname>Sun</surname><given-names>MH</given-names></name><name><surname>Wang</surname><given-names>XF</given-names></name><name><surname>Yang</surname><given-names>YJ</given-names></name><name><surname>Wang</surname><given-names>JC</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>YN</given-names></name><name><surname>Wei</surname><given-names>QY</given-names></name></person-group><article-title>A Functional Polymorphism (rs2494752) in the AKT1 Promoter Region and Gastric Adenocarcinoma Risk in an Eastern Chinese Population</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>20008</fpage><pub-id pub-id-type="doi">10.1038/srep20008</pub-id><pub-id pub-id-type="pmid">26818920</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>MY</given-names></name><name><surname>Li</surname><given-names>QX</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>LX</given-names></name><name><surname>Wang</surname><given-names>YN</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>MH</given-names></name><name><surname>Wang</surname><given-names>XF</given-names></name><name><surname>Yang</surname><given-names>YJ</given-names></name><name><surname>Wang</surname><given-names>JC</given-names></name><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Wei</surname><given-names>QY</given-names></name></person-group><article-title>Genetic variations in the mTOR gene contribute toward gastric adenocarcinoma susceptibility in an Eastern Chinese population</article-title><source>Pharmacogenet Genomics</source><year>2015</year><volume>25</volume><fpage>521</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1097/fpc.0000000000000163</pub-id><pub-id pub-id-type="pmid">26287940</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutcutache</surname><given-names>I</given-names></name><name><surname>Wu</surname><given-names>AY</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>McPherson</surname><given-names>JR</given-names></name><name><surname>Lei</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>WK</given-names></name><name><surname>Soo</surname><given-names>KC</given-names></name><name><surname>Chan</surname><given-names>WH</given-names></name><name><surname>Ooi</surname><given-names>LL</given-names></name><name><surname>Welsch</surname><given-names>R</given-names></name><name><surname>Tan</surname><given-names>P</given-names></name><name><surname>Rozen</surname><given-names>SG</given-names></name></person-group><article-title>Abundant copy-number loss of CYCLOPS and STOP genes in gastric adenocarcinoma</article-title><source>Gastric Cancer</source><year>2016</year><volume>19</volume><fpage>453</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1007/s10120-015-0514-z</pub-id><pub-id pub-id-type="pmid">26205786</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moazed</surname><given-names>D</given-names></name></person-group><article-title>Small RNAs in transcriptional gene silencing and genome defence</article-title><source>Nature</source><year>2009</year><volume>457</volume><fpage>413</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1038/nature07756</pub-id><pub-id pub-id-type="pmid">19158787</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rupaimoole</surname><given-names>R</given-names></name><name><surname>Calin</surname><given-names>GA</given-names></name><name><surname>Lopez-Berestein</surname><given-names>G</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name></person-group><article-title>miRNA Deregulation in Cancer Cells and the Tumor Microenvironment</article-title><source>Cancer Discov</source><year>2016</year><volume>6</volume><fpage>235</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.cd-15-0893</pub-id><pub-id pub-id-type="pmid">26865249</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd</surname><given-names>KA</given-names></name><name><surname>Moore</surname><given-names>AR</given-names></name><name><surname>Parsons</surname><given-names>BN</given-names></name><name><surname>O'Hara</surname><given-names>A</given-names></name><name><surname>Boyce</surname><given-names>M</given-names></name><name><surname>Dockray</surname><given-names>GJ</given-names></name><name><surname>Varro</surname><given-names>A</given-names></name><name><surname>Pritchard</surname><given-names>DM</given-names></name></person-group><article-title>Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>45462</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.9990</pub-id><pub-id pub-id-type="pmid">27323780</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>YY</given-names></name><name><surname>Zhao</surname><given-names>XD</given-names></name><name><surname>Guo</surname><given-names>HQ</given-names></name><name><surname>Liu</surname><given-names>CH</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>YN</given-names></name><name><surname>Wu</surname><given-names>KC</given-names></name><name><surname>Nie</surname><given-names>YZ</given-names></name><name><surname>Shi</surname><given-names>YQ</given-names></name><name><surname>Fan</surname><given-names>DM</given-names></name></person-group><article-title>MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1</article-title><source>Oncogene</source><year>2014</year><volume>33</volume><fpage>783</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/onc.2012.637</pub-id><pub-id pub-id-type="pmid">23353818</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Xiao</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Shen</surname><given-names>Z</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name></person-group><article-title>piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells</article-title><source>Cancer Lett</source><year>2012</year><volume>315</volume><fpage>12</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2011.10.004</pub-id><pub-id pub-id-type="pmid">22047710</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>JM</given-names></name><name><surname>Xiao</surname><given-names>BX</given-names></name><name><surname>Miao</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>QN</given-names></name></person-group><article-title>piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells</article-title><source>Clin Chim Acta</source><year>2011</year><volume>412</volume><fpage>1621</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2011.05.015</pub-id><pub-id pub-id-type="pmid">21616063</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dey</surname><given-names>BK</given-names></name><name><surname>Mueller</surname><given-names>AC</given-names></name><name><surname>Dutta</surname><given-names>A</given-names></name></person-group><article-title>Long non-coding RNAs as emerging regulators of differentiation, development, and disease</article-title><source>Transcription</source><year>2014</year><volume>5</volume><fpage>e944014</fpage><pub-id pub-id-type="doi">10.4161/21541272.2014.944014</pub-id><pub-id pub-id-type="pmid">25483404</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geisler</surname><given-names>S</given-names></name><name><surname>Coller</surname><given-names>J</given-names></name></person-group><article-title>RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts</article-title><source>Nat Rev Mol Cell Biol</source><year>2013</year><volume>14</volume><fpage>699</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1038/nrm3679</pub-id><pub-id pub-id-type="pmid">24105322</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derrien</surname><given-names>T</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Bussotti</surname><given-names>G</given-names></name><name><surname>Tanzer</surname><given-names>A</given-names></name><name><surname>Djebali</surname><given-names>S</given-names></name><name><surname>Tilgner</surname><given-names>H</given-names></name><name><surname>Guernec</surname><given-names>G</given-names></name><name><surname>Martin</surname><given-names>D</given-names></name><name><surname>Merkel</surname><given-names>A</given-names></name><name><surname>Knowles</surname><given-names>DG</given-names></name><name><surname>Lagarde</surname><given-names>J</given-names></name><name><surname>Veeravalli</surname><given-names>L</given-names></name><name><surname>Ruan</surname><given-names>X</given-names></name><etal/></person-group><article-title>The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression</article-title><source>Genome Res</source><year>2012</year><volume>22</volume><fpage>1775</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1101/gr.132159.111</pub-id><pub-id pub-id-type="pmid">22955988</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malek</surname><given-names>E</given-names></name><name><surname>Jagannathan</surname><given-names>S</given-names></name><name><surname>Driscoll</surname><given-names>JJ</given-names></name></person-group><article-title>Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer</article-title><source>Oncotarget</source><year>2014</year><volume>5</volume><fpage>8027</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.2469</pub-id><pub-id pub-id-type="pmid">25275300</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Bi</surname><given-names>J</given-names></name><name><surname>Xue</surname><given-names>X</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Zhi</surname><given-names>K</given-names></name><name><surname>Hua</surname><given-names>J</given-names></name><name><surname>Fang</surname><given-names>G</given-names></name></person-group><article-title>Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells</article-title><source>FEBS J</source><year>2012</year><volume>279</volume><fpage>3159</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2012.08694.x</pub-id><pub-id pub-id-type="pmid">22776265</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name></person-group><article-title>Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer</article-title><source>Oncotarget</source><year>2014</year><volume>5</volume><fpage>2318</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.1913</pub-id><pub-id pub-id-type="pmid">24810858</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Zhang</surname><given-names>XQ</given-names></name><name><surname>Lv</surname><given-names>JM</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>XX</given-names></name><name><surname>Xu</surname><given-names>TP</given-names></name></person-group><article-title>H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer</article-title><source>Neoplasma</source><year>2016</year><volume>63</volume><fpage>223</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.4149/207_150821n454</pub-id><pub-id pub-id-type="pmid">26774144</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashad</surname><given-names>D</given-names></name><name><surname>Elbanna</surname><given-names>A</given-names></name><name><surname>Ibrahim</surname><given-names>A</given-names></name><name><surname>Khedr</surname><given-names>G</given-names></name></person-group><article-title>Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer</article-title><source>J Clin Lab Anal</source><year>2016</year><volume>30</volume><fpage>1100</fpage><lpage>05</lpage><pub-id pub-id-type="doi">10.1002/jcla.21987</pub-id><pub-id pub-id-type="pmid">27184562</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name></person-group><article-title>Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer</article-title><source>Cell Cycle</source><year>2015</year><volume>14</volume><fpage>3112</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1080/15384101.2015.1078034</pub-id><pub-id pub-id-type="pmid">26237576</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YW</given-names></name><name><surname>Sun</surname><given-names>M</given-names></name><name><surname>Xia</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>EB</given-names></name><name><surname>Liu</surname><given-names>XH</given-names></name><name><surname>Zhang</surname><given-names>ZH</given-names></name><name><surname>Xu</surname><given-names>TP</given-names></name><name><surname>De</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>BR</given-names></name><name><surname>Wang</surname><given-names>ZX</given-names></name></person-group><article-title>LincHOTAIR epigenetically silences miR34a by binding to PRC2 to promote the epithelial-to-mesenchymal transition in human gastric cancer</article-title><source>Cell Death Dis</source><year>2015</year><volume>6</volume><fpage>e1802</fpage><pub-id pub-id-type="doi">10.1038/cddis.2015.150</pub-id><pub-id pub-id-type="pmid">26136075</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>ZY</given-names></name><name><surname>Yu</surname><given-names>QM</given-names></name><name><surname>Du</surname><given-names>YA</given-names></name><name><surname>Yang</surname><given-names>LT</given-names></name><name><surname>Dong</surname><given-names>RZ</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>PF</given-names></name><name><surname>Cheng</surname><given-names>XD</given-names></name></person-group><article-title>Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer</article-title><source>Int J Biol Sci</source><year>2013</year><volume>9</volume><fpage>587</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.7150/ijbs.6339</pub-id><pub-id pub-id-type="pmid">23847441</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Gu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Zhong</surname><given-names>B</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Hoffman</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name></person-group><article-title>Long noncoding RNA HOTAIR as an independent prognostic marker in cancer: a meta-analysis</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e105538</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0105538</pub-id><pub-id pub-id-type="pmid">25157956</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fei</surname><given-names>ZH</given-names></name><name><surname>Yu</surname><given-names>XJ</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Su</surname><given-names>HF</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Xie</surname><given-names>CY</given-names></name></person-group><article-title>Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>1983</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1007/s13277-015-3979-9</pub-id><pub-id pub-id-type="pmid">26334618</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Su</surname><given-names>HF</given-names></name><name><surname>Fang</surname><given-names>N</given-names></name><name><surname>Zou</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>WF</given-names></name><name><surname>Fei</surname><given-names>ZH</given-names></name></person-group><article-title>Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition</article-title><source>J Hematol Oncol</source><year>2016</year><volume>9</volume><fpage>57</fpage><pub-id pub-id-type="doi">10.1186/s13045-016-0288-8</pub-id><pub-id pub-id-type="pmid">27439973</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Cao</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name></person-group><article-title>SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma</article-title><source>Tumour Biol</source><year>2016</year><volume>37</volume><fpage>2379</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1007/s13277-015-4052-4</pub-id><pub-id pub-id-type="pmid">26373735</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N</given-names></name><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name></person-group><article-title>Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>11271</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.7168</pub-id><pub-id pub-id-type="pmid">26848625</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>YS</given-names></name><name><surname>Wang</surname><given-names>XW</given-names></name><name><surname>Zhou</surname><given-names>XL</given-names></name><name><surname>Liu</surname><given-names>ZH</given-names></name><name><surname>Yang</surname><given-names>TX</given-names></name><name><surname>Shi</surname><given-names>WH</given-names></name><name><surname>Xie</surname><given-names>HW</given-names></name><name><surname>Lv</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>QQ</given-names></name><name><surname>Cao</surname><given-names>XF</given-names></name></person-group><article-title>Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma</article-title><source>Mol Cancer</source><year>2015</year><volume>14</volume><fpage>3</fpage><pub-id pub-id-type="doi">10.1186/1476-4598-14-3</pub-id><pub-id pub-id-type="pmid">25608466</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>MY</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Skogerboe</surname><given-names>G</given-names></name><etal/></person-group><article-title>LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma</article-title><source>Gut</source><year>2014</year><volume>63</volume><fpage>1700</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2013-305806</pub-id><pub-id pub-id-type="pmid">24522499</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>CK</given-names></name></person-group><article-title>Analysis of RNA-Seq Data Using TopHat and Cufflinks</article-title><source>Methods Mol Biol</source><year>2016</year><volume>1374</volume><fpage>339</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-3167-5_18</pub-id><pub-id pub-id-type="pmid">26519415</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Benesty</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Cohen</surname><given-names>I</given-names></name></person-group><year>2009</year><chapter-title>Pearson correlation coefficient</chapter-title><source>Noise reduction in speech processing</source><publisher-name>Springer</publisher-name><fpage>1</fpage><lpage>4</lpage></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Schwikowski</surname><given-names>B</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title><source>Genome Res</source><year>2003</year><volume>13</volume><fpage>2498</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kawashima</surname><given-names>M</given-names></name><name><surname>Furumichi</surname><given-names>M</given-names></name><name><surname>Tanabe</surname><given-names>M</given-names></name></person-group><article-title>KEGG as a reference resource for gene and protein annotation</article-title><source>Nucleic Acids Res</source><year>2016</year><volume>44</volume><fpage>D457</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">26476454</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>XJ</given-names></name></person-group><article-title>GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis</article-title><source>Nucleic Acids Res</source><year>2008</year><volume>36</volume><fpage>W358</fpage><lpage>W63</lpage><pub-id pub-id-type="pmid">18487275</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Kong</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>CY</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name></person-group><article-title>KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>W316</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr483</pub-id><pub-id pub-id-type="pmid">21715386</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmittgen</surname><given-names>TD</given-names></name><name><surname>Livak</surname><given-names>KJ</given-names></name></person-group><article-title>Analyzing real-time PCR data by the comparative C(T) method</article-title><source>Nat Protoc</source><year>2008</year><volume>3</volume><fpage>1101</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18546601</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name></person-group><article-title>Advanced heat map and clustering analysis using heatmap3</article-title><year>2014</year><volume>2014</volume><comment>986048</comment><pub-id pub-id-type="doi">10.1155/2014/986048</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Carey</surname><given-names>V</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Irizarry</surname><given-names>R</given-names></name><name><surname>Dudoit</surname><given-names>S</given-names></name></person-group><source>Bioinformatics and computational biology solutions using R and Bioconductor</source><publisher-name>Springer Science &amp; Business Media</publisher-name><year>2006</year></element-citation></ref></ref-list></back></article>